David Molkentine
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics, Head and Neck Cancer Studies, PARP inhibition in cancer therapy
Most-Cited Works
- → MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma(2023)157 cited
- → CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors(2024)123 cited
- → Integrative Analysis Identifies a Novel AXL–PI3 Kinase–PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer(2017)115 cited
- → DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy(2011)92 cited
- → Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer(2016)76 cited
- → Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro(2011)75 cited
- → C-Met Inhibitor MK-8003 Radiosensitizes c-Met–Expressing Non–Small-Cell Lung Cancer Cells With Radiation-Induced c-Met–Expression(2012)73 cited
- → Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways(2012)55 cited
- → TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects(2016)54 cited
- → A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe(2009)50 cited